|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
End of the Road for Torrey Path as Founder Starts New Trail with Sequencethree
|
Bruce V. Bigelow |
06/14/11 |
San Diego
|
|
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO
|
Luke Timmerman |
04/27/11 |
Seattle
|
|
Adimab Inks Novartis Deal, GSK-Founded Tempero Pursues Hot Immunology Field, Metamark Gets $22M, & More Boston-Area Life Sciences News
|
Erin Kutz |
07/16/10 |
Boston
|
|
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology
|
Ryan McBride |
07/15/10 |
Boston
|
|
Nathan Myhrvold, Lee Hood Forge Longstanding Partnership at Nexus of IT and Biology
|
Luke Timmerman |
03/24/10 |
Seattle
|
|
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent
|
Luke Timmerman |
10/09/09 |
National
|
|
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 1)
|
Luke Timmerman |
09/23/09 |
Seattle
|
|
Seattle-based Kineta, New Biotech Startup, Unveils Plan to Trigger Innate Immunity
|
Luke Timmerman |
12/09/08 |
Seattle
|
|
Paul Allen’s WWII Planes Show How Innovation Can Soar Ahead
|
Luke Timmerman |
08/21/08 |
Seattle
|
|
Immune Design Aiming To Make Vaccines That Work Better in a Single Shot
|
Luke Timmerman |
07/07/08 |
Seattle
|
|
Immune Design, Led By Star Scientists, Raises $18 Million To Build Vaccine Company
|
Luke Timmerman |
06/23/08 |
Seattle
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.